5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
A guide to how pioglitazone (Actos) affects growth, hormonal development, bone density, and metabolic health in adolescents aged 12 to 17, with evidence-based dosing context and safety considerations.
A clinical guide for teens aged 12-17 taking pioglitazone (Actos) as they move from pediatric to adult diabetes care, covering dosing, safety monitoring, shared decision-making, and what to expect at the first adult endocrinology visit.
A complete caregiver guide to administering pioglitazone (Actos) in adults aged 65 and older, covering dosing, fall risk, fluid retention, drug interactions, and when to call the prescriber.
A guide to pioglitazone use in patients aged 65+, covering pharmacokinetics, cardiovascular and bone outcomes, cognitive effects, dosing considerations, and monitoring protocols specific to older adults with type 2 diabetes.
A clinical guide to transitioning young patients from pediatric to adult care when pioglitazone (Actos) is part of their treatment plan, covering safety data, dosing, FDA labeling, and how to coordinate care across providers.